fda shortage semaglutide injection products resolved feb 21 2025 Declares of Novo Nordisk's Wegovy, Ozempic Over Federal judge upholds FDA's removal

Glucagon-like Peptide-1 (GLP-1) Agonists Recent Developments In June 2026, Viking Therapeutics announced on June 24 the initiation of its Phase 1 clinical trial evaluating VK3019, an investigational dual amylin and calcitonin receptor agonist (DACRA)

Green Tea Polyphenol Epigallocatechin-3-Gallate Differentially Modulates Nuclear Factor kappaB in Cancer Cells versus Normal Cells

Gao FM, Ali AS, Bellomo R, Gaca M, Lecamwasam A, Churilov L, Ekinci EI

Considering several benefits of NAC in patients with PCOS, there is still unresolved controversy among clinical trials investigating the efficiency of NAC supplementation in improving ovulation and sex hormones profile in PCOS patients

However, other studies have failed to show significant improvement in symptoms such as headaches, nausea, or fatigue